trial · primary record
SGN1
Advanced Solid Tumor
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 70 |
| Primary completion | 2028-08-31 |
| Primary endpoint | Incidence and severity of AEs (adverse events). |
| Registry ID | NCT05038150 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:19.963Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05038150
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.